The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles.

We explore the neurobiological bases of attention deficit hyperactivity disorder (ADHD) from the viewpoint of the neurochemistry and psychopharmacology of the catecholamine-based behavioural systems. The contributions of dopamine (DA) and noradrenaline (NA) neurotransmission to the motor and cognitive symptoms of ADHD (e.g. hyperactivity, variable and impulsive responses) are studied in rodent and primate models. These models represent elements of the behavioural units observed in subjects with ADHD clinically, or in laboratory settings (e.g. locomotion, changed sensitivity/responsivity to novelty/reinforcement and measures of executive processing). In particular, the models selected emphasize traits that are strongly influenced by mesocorticolimbic DA in the spontaneously hypertensive (SHR) and the Naples high excitability (NHE) rat lines. In this context, the mode of action of methylphenidate treatment is discussed. We also describe current views on the altered control by mesolimbic catecholamines of appropriate and inappropriate goal-directed behaviour, and the tolerance or intolerance of delayed reinforcement in ADHD children and animal models. Recent insights into the previously underestimated role of the NA system in the control of mesocortical DA function, and the frontal role in processing information are elaborated.

[1]  V. Russell,et al.  Animal models of attention-deficit hyperactivity disorder , 2005, Behavioral and Brain Functions.

[2]  V. Russell,et al.  A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. , 2005, The Behavioral and brain sciences.

[3]  S. Mingote,et al.  Noradrenaline and Dopamine Efflux in the Prefrontal Cortex in Relation to Appetitive Classical Conditioning , 2004, The Journal of Neuroscience.

[4]  G. Gessa,et al.  Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex. , 2004, European journal of pharmacology.

[5]  Grégory Dal Bo,et al.  Dopamine neurons in culture express VGLUT2 explaining their capacity to release glutamate at synapses in addition to dopamine , 2004, Journal of neurochemistry.

[6]  A. Carlsson,et al.  Schizophrenia: from dopamine to glutamate and back. , 2004, Current medicinal chemistry.

[7]  C. Weickert,et al.  High‐level expression of Dok‐1 in neurons of the primate prefrontal cortex and hippocampus , 2004, Journal of neuroscience research.

[8]  T. Robbins,et al.  Inhibitory control in rats performing a stop-signal reaction-time task: effects of lesions of the medial striatum and d-amphetamine. , 2003, Behavioral neuroscience.

[9]  D. Viggiano,et al.  Dopamine phenotype and behaviour in animal models: in relation to attention deficit hyperactivity disorder , 2003, Neuroscience & Biobehavioral Reviews.

[10]  G. Chiara,et al.  Effect of amphetamine, cocaine and depolarization by high potassium on extracellular dopamine in the nucleus accumbens shell of SHR rats. An in vivo microdyalisis study , 2003, Neuroscience & Biobehavioral Reviews.

[11]  D. Greco,et al.  Altered midbrain dopaminergic neurotransmission during development in an animal model of ADHD , 2003, Neuroscience & Biobehavioral Reviews.

[12]  S. Ferguson,et al.  In vivo basal and amphetamine-induced striatal dopamine and metabolite levels are similar in the spontaneously hypertensive, Wistar–Kyoto and Sprague–Dawley male rats , 2003, Physiology & Behavior.

[13]  T. Robbins,et al.  Global 5-HT depletion attenuates the ability of amphetamine to decrease impulsive choice on a delay-discounting task in rats , 2003, Psychopharmacology.

[14]  I. Maidment.  The Use of Antidepressants to Treat Attention Deficit Hyperactivity Disorder in Adults , 2003, Journal of psychopharmacology.

[15]  T. Südhof,et al.  α-Neurexins couple Ca2+ channels to synaptic vesicle exocytosis , 2003, Nature.

[16]  V. Russell.  In Vitro Glutamate-Stimulated Release of Dopamine from Nucleus Accumbens Core and Shell of Spontaneously Hypertensive Rats , 2003, Metabolic Brain Disease.

[17]  S. Ferguson,et al.  A longitudinal study of short- and long-term activity levels in male and female spontaneously hypertensive, Wistar-Kyoto, and Sprague-Dawley rats. , 2003, Behavioral neuroscience.

[18]  C. Berridge,et al.  The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes , 2003, Brain Research Reviews.

[19]  T. Robbins,et al.  Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans , 2003, Nature Neuroscience.

[20]  K. Perry,et al.  Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder , 2002, Neuropsychopharmacology.

[21]  D. Vallone,et al.  The Naples High- and Low-Excitability Rats: Selective Breeding, Behavioral Profile, Morphometry, and Molecular Biology of the Mesocortical Dopamine System , 2002, Behavior genetics.

[22]  F. Castellanos,et al.  Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes , 2002, Nature Reviews Neuroscience.

[23]  A. Goodchild,et al.  Tyrosine hydroxylase gene expression in ventrolateral medulla oblongata of WKY and SHR: a quantitative real-time polymerase chain reaction study , 2002, Autonomic Neuroscience.

[24]  M. Pignatelli,et al.  Environmental factors during postnatal period modify activity and non-selective attention in the Naples High-Excitability rat , 2002, Behavioural Brain Research.

[25]  E. Sonuga-Barke,et al.  Psychological heterogeneity in AD/HD—a dual pathway model of behaviour and cognition , 2002, Behavioural Brain Research.

[26]  R. Oades.  Dopamine may be ‘hyper’ with respect to noradrenaline metabolism, but ‘hypo’ with respect to serotonin metabolism in children with attention-deficit hyperactivity disorder , 2002, Behavioural Brain Research.

[27]  Tim Shallice,et al.  Executive Function Profile of Children With Attention Deficit Hyperactivity Disorder , 2002, Developmental neuropsychology.

[28]  B. Moghaddam,et al.  NMDA antagonist effects on striatal dopamine release: Microdialysis studies in awake monkeys , 2002, Synapse.

[29]  R. Oades,et al.  Serotonin Platelet-Transporter Measures in Childhood Attention-Deficit/Hyperactivity Disorder (ADHD): Clinical versus Experimental Measures of Impulsivity , 2002, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[30]  G. Flore,et al.  Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex , 2001, Molecular Psychiatry.

[31]  E. Taylor,et al.  Neuropsychological analyses of impulsiveness in childhood hyperactivity , 2001, British Journal of Psychiatry.

[32]  R. Schultz,et al.  A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. , 2001, The American journal of psychiatry.

[33]  B. Alsop,et al.  Sensitivity to reward delay in children with attention deficit hyperactivity disorder (ADHD). , 2001, Journal of child psychology and psychiatry, and allied disciplines.

[34]  Gordon D. Logan,et al.  The Ecological Validity of Delay Aversion and Response Inhibition as Measures of Impulsivity in AD/HD: A Supplement to the NIMH Multimodal Treatment Study of AD/HD , 2001, Journal of abnormal child psychology.

[35]  T. Robbins,et al.  Impulsive Choice Induced in Rats by Lesions of the Nucleus Accumbens Core , 2001, Science.

[36]  S. Faraone,et al.  The nature and heritability of attention-deficit/hyperactivity disorder. , 2001, Child and adolescent psychiatric clinics of North America.

[37]  D. A. Bergstrom,et al.  Drugs used in the treatment of attention-deficit/hyperactivity disorder affect postsynaptic firing rate and oscillation without preferential dopamine autoreceptor action , 2001, Biological Psychiatry.

[38]  T. Sejnowski,et al.  Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. O. Schenk,et al.  Characterization of Extracellular Dopamine Clearance in the Medial Prefrontal Cortex: Role of Monoamine Uptake and Monoamine Oxidase Inhibition , 2001, The Journal of Neuroscience.

[40]  V. Russell,et al.  Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder — the spontaneously hypertensive rat , 2000, Behavioural Brain Research.

[41]  G. Elston,et al.  Pyramidal Cells, Patches, and Cortical Columns: a Comparative Study of Infragranular Neurons in TEO, TE, and the Superior Temporal Polysensory Area of the Macaque Monkey , 2000, The Journal of Neuroscience.

[42]  A. Scheres,et al.  Response Inhibition and Measures of Psychopathology: A Dimensional Analysis , 2000, Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence.

[43]  Mario Liotti,et al.  Inhibitory control in children with attention-deficit/hyperactivity disorder: event-related potentials identify the processing component and timing of an impaired right-frontal response-inhibition mechanism , 2000, Biological Psychiatry.

[44]  P F Renshaw,et al.  Using MRI to examine brain-behavior relationships in males with attention deficit disorder with hyperactivity. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[45]  Adrian M. Owen,et al.  Methylphenidate Enhances Working Memory by Modulating Discrete Frontal and Parietal Lobe Regions in the Human Brain , 2000, The Journal of Neuroscience.

[46]  A. Sadile.  Multiple evidence of a segmental defect in the anterior forebrain of an animal model of hyperactivity and attention deficit , 2000, Neuroscience & Biobehavioral Reviews.

[47]  P. Goldman-Rakic.  The Relevance of the Dopamine-D1 Receptor in the Cognitive Symptoms of Schizophrenia , 1999, Neuropsychopharmacology.

[48]  Holly Moore,et al.  The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia , 1999, Biological Psychiatry.

[49]  E D Levin,et al.  Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. , 1999, Science.

[50]  N. Volkow,et al.  Differences in regional brain metabolic responses between single and repeated doses of methylphenidate , 1998, Psychiatry Research: Neuroimaging.

[51]  Terje Sagvolden,et al.  Differences between electrically-, ritalin- and d-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of Attention-Deficit Hyperactivity Disorder , 1998, Behavioural Brain Research.

[52]  R. D. Oades,et al.  Frontal, temporal and lateralized brain function in children with attention-deficit hyperactivity disorder: a psychophysiological and neuropsychological viewpoint on development , 1998, Behavioural Brain Research.

[53]  Jaap Oosterlaan,et al.  Inhibitory dysfunction in hyperactive boys , 1998, Behavioural Brain Research.

[54]  J. Sergeant,et al.  Attention deficit/hyperactivity disorder--from brain dysfunctions to behaviour. , 1998, Behavioural brain research.

[55]  Heidi Aase,et al.  Altered reinforcement mechanisms in attention-deficit/hyperactivity disorder , 1998, Behavioural Brain Research.

[56]  P S Goldman-Rakic,et al.  Widespread origin of the primate mesofrontal dopamine system. , 1998, Cerebral cortex.

[57]  G. Aston-Jones,et al.  Conditioned responses of monkey locus coeruleus neurons anticipate acquisition of discriminative behavior in a vigilance task , 1997, Neuroscience.

[58]  M. Fujita,et al.  Brain dopamine transporter in spontaneously hypertensive rats. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[59]  P. Goldman-Rakic,et al.  Modulation of memory fields by dopamine Dl receptors in prefrontal cortex , 1995, Nature.

[60]  A. C. Linthorst,et al.  The nigrostriatal dopamine system and the development of hypertension in the spontaneously hypertensive rat. , 1995, Archives des maladies du coeur et des vaisseaux.

[61]  Terje Sagvolden,et al.  Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder — the spontaneously hypertensive rat , 1995, Brain Research.

[62]  T. Sagvolden,et al.  Spontaneously hypertensive rats (SHR) as a putative animal model of childhood hyperkinesis: SHR behavior compared to four other rat strains , 1993, Physiology & Behavior.

[63]  H. Welzl,et al.  Circadian activity, nociceptive thresholds, nigrostriatal and mesolimbic dopaminergic activity in the Naples High- and Low-Excitability rat lines , 1993, Behavioural Brain Research.

[64]  W. Schultz,et al.  Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[65]  P. Ganguly,et al.  Up-regulation of dopamine receptors in the brain of the spontaneously hypertensive rat: An autoradiographic analysis , 1993, Neuroscience.

[66]  M. A. Metzger,et al.  The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulants. , 1992, Behavioral and neural biology.

[67]  J. Rapoport,et al.  Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true nonresponders? , 1991, Psychiatry Research.

[68]  G. Gessa,et al.  Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants. , 1990, European journal of pharmacology.

[69]  Trevor W. Robbins,et al.  Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: Implications for theories of selective attention and arousal , 1989, Behavioural Brain Research.

[70]  R. Oades.  The role of noradrenaline in tuning and dopamine in switching between signals in the CNS , 1985, Neuroscience & Biobehavioral Reviews.

[71]  M. Solanto.  Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis. , 1984, Psychological bulletin.

[72]  Davide Viggiano,et al.  Dysfunctions in Dopamine Systems and ADHD: Evidence From Animals and Modeling , 2004, Neural plasticity.

[73]  M. Owen,et al.  Association of the dopamine D4 receptor gene 7-repeat allele with neuropsychological test performance of children with ADHD. , 2004, The American journal of psychiatry.

[74]  A. Grace.  Psychostimulant actions on dopamine and limbic system function: Relevance to the pathophysiology and treatment of ADHD. , 2001 .

[75]  A. Arnsten.  Dopaminergic and noradrenergic influences on cognitive functions mediated by prefrontal cortex. , 2001 .

[76]  F. Castellanos,et al.  Stimulant drugs and ADHD : basic and clinical neuroscience , 2001 .

[77]  R. Barkley.  Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. , 1997, Psychological bulletin.

[78]  B. Pitt.  Psychopharmacology , 1968, Mental Health.